GT199600072A - Formas zwitterionicas de trovafloxacina. - Google Patents

Formas zwitterionicas de trovafloxacina.

Info

Publication number
GT199600072A
GT199600072A GT199600072A GT199600072A GT199600072A GT 199600072 A GT199600072 A GT 199600072A GT 199600072 A GT199600072 A GT 199600072A GT 199600072 A GT199600072 A GT 199600072A GT 199600072 A GT199600072 A GT 199600072A
Authority
GT
Guatemala
Prior art keywords
trovafloxacin
refers
zwitterionic forms
procedures
naftiridone
Prior art date
Application number
GT199600072A
Other languages
English (en)
Spanish (es)
Inventor
Douglas John Meldrum Allen
David Bruning Joseph
Timothy Norris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199600072A publication Critical patent/GT199600072A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
GT199600072A 1995-08-29 1996-08-23 Formas zwitterionicas de trovafloxacina. GT199600072A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
GT199600072A true GT199600072A (es) 1998-02-14

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199600072A GT199600072A (es) 1995-08-29 1996-08-23 Formas zwitterionicas de trovafloxacina.

Country Status (30)

Country Link
EP (1) EP0850060A1 (sh)
JP (1) JP3188476B2 (sh)
KR (1) KR100343909B1 (sh)
CN (1) CN1190889A (sh)
AP (1) AP636A (sh)
AR (1) AR003985A1 (sh)
AU (1) AU704115B2 (sh)
BR (1) BR9609998A (sh)
CA (1) CA2229786C (sh)
CO (1) CO4480739A1 (sh)
CZ (1) CZ56698A3 (sh)
DZ (1) DZ2087A1 (sh)
GT (1) GT199600072A (sh)
HR (1) HRP960395B1 (sh)
HU (1) HUP9900170A3 (sh)
IL (1) IL122651A (sh)
MA (1) MA23966A1 (sh)
MY (1) MY113874A (sh)
NO (1) NO309814B1 (sh)
NZ (1) NZ312199A (sh)
OA (1) OA10669A (sh)
PE (1) PE12598A1 (sh)
PL (1) PL325170A1 (sh)
RU (1) RU2144921C1 (sh)
SK (1) SK23898A3 (sh)
TN (1) TNSN96109A1 (sh)
TR (1) TR199800339T1 (sh)
WO (1) WO1997007800A1 (sh)
YU (1) YU48396A (sh)
ZA (1) ZA967282B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
ZA967282B (en) 1998-03-02
JPH10511692A (ja) 1998-11-10
KR19990044232A (ko) 1999-06-25
MY113874A (en) 2002-06-29
EP0850060A1 (en) 1998-07-01
AU6367696A (en) 1997-03-19
IL122651A0 (en) 1998-08-16
JP3188476B2 (ja) 2001-07-16
CA2229786A1 (en) 1997-03-06
AR003985A1 (es) 1998-09-30
HUP9900170A3 (en) 1999-11-29
AP636A (en) 1998-04-09
AP9600853A0 (en) 1996-10-31
CO4480739A1 (es) 1997-07-09
NO980862D0 (no) 1998-02-27
MX9801664A (es) 1998-08-30
IL122651A (en) 2000-02-17
WO1997007800A1 (en) 1997-03-06
NO309814B1 (no) 2001-04-02
YU48396A (sh) 1998-12-23
BR9609998A (pt) 1999-07-06
TR199800339T1 (xx) 1998-06-22
OA10669A (en) 2000-11-06
PL325170A1 (en) 1998-07-06
NO980862L (no) 1998-02-27
TNSN96109A1 (fr) 2005-03-15
PE12598A1 (es) 1998-03-20
KR100343909B1 (ko) 2003-04-10
MA23966A1 (fr) 1997-04-01
DZ2087A1 (fr) 2002-07-22
HUP9900170A2 (hu) 1999-05-28
HRP960395A2 (en) 1998-06-30
RU2144921C1 (ru) 2000-01-27
AU704115B2 (en) 1999-04-15
CA2229786C (en) 2002-02-19
HRP960395B1 (en) 2001-12-31
CN1190889A (zh) 1998-08-19
NZ312199A (en) 1999-06-29
CZ56698A3 (cs) 1999-02-17
SK23898A3 (en) 1999-05-07

Similar Documents

Publication Publication Date Title
UY28510A1 (es) Compuestos quimicos
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
UY25330A1 (es) Nuevos macrólidos
HN1999000124A (es) Derivados de pirazol substituido.
ES2181614T3 (es) Sulfonilfenilheterociclos sustituidos como inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa.
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
AR026410A1 (es) ''2-aril-3-(heteroaril)-imidazo[1,2-a]pirimidinas sustituidas, y las composiciones y metodos farmaceuticos relacionados
ECSP099451A (es) Compuestos de urea policíclicos antibacterianos
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
UY25780A1 (es) Nuevos antibióticos macrólidos
AR037654A1 (es) Base libre de clindamicina sustancialmente cristalina, sustancia droga, composicion farmaceutica y su uso en la fabricacion de un medicamento y proceso para preparar dicha base libre cristalina de clindamicina
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
UY28542A1 (es) Amidas macrocíclicas antibacterianas
GT199600072A (es) Formas zwitterionicas de trovafloxacina.
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
ES2167721T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica.
AR021463A1 (es) Antibiotico de piridona con perfil de seguridad mejorado
HN2001000002A (es) PIRAZOLO [4,3-e] DIAZEPINAS SUSTITUIDAS NOVEDOSAS, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN, SU USO COMO PRODUCTOS MEDICINALES Y PROCESOS PARA PREPARARLAS.
ECSP961850A (es) Formas switterionicas de trovafloxacina
GT200000114A (es) Forma cristalina iii de la n-(4-(5-dimetilaminoftalen-1-sulfonilamino) fenil)-3-hidroxi-2, 2-dimetilpropionamida.